EPA and ADHD

 
 
 

Symptoms of ADHD (Attention Deficit Hyperactivity Disorder), that include difficulty staying focused, paying attention, controlling behavior and hyperactivity, appear between the ages of 3 and 6 and can continue through adolescence and adulthood. ADHD has three subtypes: predominantly hyperactive-impulsive, predominantly inattentive and both combined (most children have this last type).

Although pharmacological treatments have demonstrated short-term efficacy for ADHD, many families prefer not to use traditional pharmacotherapies to treat it because of the possible side effects (the most usual are decreased appetite, sleep problems and repetitive movements or sounds called tics) and the lack of awareness on the long-term efficacy or effects on development of these medications.

An analysis of 10 separate but similar experiments of different researchers (involving 699 children) shown a modest but significant effect of omega-3 fatty acid supplementation for ADHD and the same for the treatment of inattentive and hyperactivity symptoms separately. Within omega-3 supplements, higher doses of EPA were significantly associated with increased efficacy in treating ADHD symptoms.

EPA supplementation, given its benign side-effect profile, is a reasonable complementary treatment to traditional medications or, for those families who reject them, a plausible alternative treatment.

References:
 
TDAH
 

Omega-3 in monotherapy for ADHD

Attention deficit/hyperactivity disorder (ADHD) is a chronic, debilitating disorder which may affect all aspects of a child’s life (including academic difficulties, social skills p[...]

 
 

Restoring omega-6/omega-3 balance in ADHD

Attention Deficit Hyperactivity Disorder (ADHD) is a common neurological development disorder characterized by symptoms of inattention, hyperactivity, and impulsivity, among whose [...]